Acta Oto-LaryngologicaPub Date : 2024-10-01Epub Date: 2024-10-21DOI: 10.1080/00016489.2024.2415493
Mingbao Yang, Bei Zhang, Yafeng Guan
{"title":"Hearing outcomes in subtotal facial nerve decompression with preserving ossicular chain intact.","authors":"Mingbao Yang, Bei Zhang, Yafeng Guan","doi":"10.1080/00016489.2024.2415493","DOIUrl":"10.1080/00016489.2024.2415493","url":null,"abstract":"<p><strong>Background: </strong>Facial paralysis patients with normal hearing often require ossicular chain dislocation throughout the entire process of facial nerve decompression surgery, and their hearing tends to be slightly impaired after surgery. There is not detailed explanation of hearing changes after facial nerve decompression with preserving intact ossicular chain.</p><p><strong>Purpose: </strong>This study aimed to determine the efficacy and hearing outcomes of facial nerve decompression with preserving ossicular chain intact transmastoid supralabyrinthine recess pathway in Bell's palsy.</p><p><strong>Methods: </strong>A retrospective study comparing the pre- and post-operative facial nerve HB functional grades and hearing results of 12 patients with Bell's palsy who underwent facial nerve decompression.</p><p><strong>Results: </strong>Preoperative and postoperative mean House-Brackmann (HB) scores respectively were 4.41 ± 0.67 and 1.58 ± 0.79 grades; The recovery rate to HB grade I, II was 100% or to grade III or lower was 83.3% (10/12). The pre- and post-operative mean PTAs (0.125, 0.25, 0.5, 1, 2, 4, 8KHz) were 19.1 ± 1.9 dB and 36.8 ± 4.1 dB; The pre- and postoperative low frequencies (0.125, 0.25KHz) were 18.5 ± 2.3 dB and 26 ± 3.8 dB; The pre- and postoperative speech frequencies (0.5, 1, 2KHz) mean PTAs were 18.5 ± 1.9 dB and 21.5 ± 2.9 dB; Comparison of pre- and post-operative hearing outcomes at all frequencies, low frequencies, and speech frequencies showed no statistically significant differences (<b><i>p</i> </b><<b> </b>0.05); The pre- and postoperative high frequencies (4, 8KHz) were 20.6 ± 4.7 dB and 70.4 ± 11.6 dB and the hearing outcomes were statistically significant (<b><i>p</i></b> >0.05).</p><p><strong>Conclusion: </strong>Subtotal facial nerve decompression with preserving ossicular chain intact transmastoid supralabyrinthine recess pathway does not cause the verbal frequency hearing loss of Bell's palsy, but it has high frequency sensorineural hearing loss, which tend to be unavoidable and independent of the skill of the surgical operator.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"574-579"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta Oto-LaryngologicaPub Date : 2024-10-01Epub Date: 2024-10-22DOI: 10.1080/00016489.2024.2416082
Shin-Ichi Usami, Shin-Ya Nishio, Javier Gavilán, Paul Van de Heyning, Griet Mertens, Eva Karltorp, Henryk Skarżyński, Abdulrahman Hagr, Manikoth Manoj, Hinrich Staecker, Mario E Zernotti, Gunesh P Rajan, Joachim Müller, Florian Simon, Ilona Anderson
{"title":"HEARRING group genetic marker study: genetic background of CI patients.","authors":"Shin-Ichi Usami, Shin-Ya Nishio, Javier Gavilán, Paul Van de Heyning, Griet Mertens, Eva Karltorp, Henryk Skarżyński, Abdulrahman Hagr, Manikoth Manoj, Hinrich Staecker, Mario E Zernotti, Gunesh P Rajan, Joachim Müller, Florian Simon, Ilona Anderson","doi":"10.1080/00016489.2024.2416082","DOIUrl":"10.1080/00016489.2024.2416082","url":null,"abstract":"<p><strong>Background: </strong>While cochlear implantation (CI) and electric acoustic stimulation (EAS) have a positive outcome in most cases, their effectiveness varies depending on the etiology of the hearing loss. Among the various etiologies, genetic factors are the leading cause of hearing loss and may impact CI and EAS outcomes.</p><p><strong>Aims/objectives: </strong>To reveal the genetic background of the hearing loss in CI/EAS patients in each ethnic population, we undertook a multi-center study involving the genetic testing of hearing loss in CI/EAS patients from 10 centers.</p><p><strong>Material and methods: </strong>Saliva samples and clinical information for the patients and their family members were obtained and next-generation sequencing analysis using a panel carrying 63 deafness genes was then performed.</p><p><strong>Results: </strong>Genetic testing successfully identified the causative gene variants in 54.5% (48/88) of patients with pre-lingual onset hearing loss (onset under 6 years) and in 12% (12/95) of those with late-onset hearing loss (onset at 6 years or more).</p><p><strong>Conclusions and significance: </strong>We clearly indicated that genetic factors are the most common cause of hearing loss regardless of ethnic background. Saliva-based genetic testing is a useful tool for multi-center studies seeking to clarify the genetic causes of hearing loss in CI or EAS patients between countries separated by distance.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"542-551"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study.","authors":"Elnaz Sepehri,Bo Tideholm,Sten Hellström,Cecilia Engmér Berglin","doi":"10.1080/00016489.2024.2396488","DOIUrl":"https://doi.org/10.1080/00016489.2024.2396488","url":null,"abstract":"BACKGROUNDThere is a need for a simpler and accessible intervention to heal tympanic membrane perforations than myringoplasty that is todaýs golden standard. Experimental studies have identified plasminogen as a promising agent for medical treatment of chronic tympanic membrane perforation.AIMS/OBJECTIVESThis was a phase 1, prospective, randomized, placebo-controlled study with the main objective to evaluate the safety of injecting plasminogen in the vicinity of the tympanic membrane in subjects with chronic tympanic membrane perforation.MATERIAL AND METHODSAdults diagnosed with a dry chronic tympanic membrane perforation were recruited for an injection schedule with Human plasminogen 10. Adverse events, audiometry, VAS fluctuations and size of perforation, were monitored throughout the length of the study.RESULTSIt was possible to perform the injections according to schedule in all subjects. None of the subjects experienced any severe adverse events. Most common adverse event was ear pain. No signs of ototoxicity were reported.CONCLUSIONS AND SIGNIFICANCEThis pilot study suggests that plasminogen injections close to the tympanic membrane as treatment for chronic tympanic membrane injections are safe and feasible, encouraging further dose-escalating studies.","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":"8 1","pages":"1-7"},"PeriodicalIF":1.4,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142227166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The impact of adverse reactions on adherence to sublingual immunotherapy for Japanese cedar pollinosis and house dust mite allergy in Japan.","authors":"Satoru Masuno","doi":"10.1080/00016489.2024.2397054","DOIUrl":"https://doi.org/10.1080/00016489.2024.2397054","url":null,"abstract":"BACKGROUNDAllergen immunotherapy is the only treatment that can achieve remission for allergic diseases.AIMS/OBJECTIVESTo investigate the three-year adherence to sublingual immunotherapy for Japanese cedar pollinosis and house dust mite allergy at a clinic in Japan and identify factors that influence adherence and severe adverse reactions.MATERIAL AND METHODSIn total, 174 patients aged 12 years or older who started sublingual immunotherapy for Japanese cedar pollinosis (n = 72), house dust mite allergy (n = 55), or both (n = 47) between May 2017 and June 2018. Patient age, sex, type of pharmacotherapy used, adverse reactions, blood test results, and duration of continuous treatment were investigated.RESULTSThe three-year treatment continuation rate was 40.8%. Adverse reaction rates were 12.6% for cedar pollinosis and 40.2% for house dust mite allergy. Patients with dose reductions due to severe reactions had lower first-year continuation rates. In the MITICURE® group, patients with severe reactions had significantly higher serum total IgE levels. Severe reactions were more common in MITICURE® patients with seven or more positive antigen types.CONCLUSIONS AND SIGNIFICANCESevere adverse reactions reduced early adherence.","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":"59 1","pages":"1-9"},"PeriodicalIF":1.4,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142217335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta Oto-LaryngologicaPub Date : 2024-09-01Epub Date: 2024-09-20DOI: 10.1080/00016489.2024.2400299
Haidong Zhang, Kai Sun, Shanchun Gong, Lijuan Zhou, Siping Liang, Chao Wang, Kai Liu, Xianjun Lyn, Zhenkun Yu
{"title":"Application of covered stent implantation combined with radical tumor resection in advanced head and neck squamous cell carcinoma involving the carotid artery: a comparative study with historical literature.","authors":"Haidong Zhang, Kai Sun, Shanchun Gong, Lijuan Zhou, Siping Liang, Chao Wang, Kai Liu, Xianjun Lyn, Zhenkun Yu","doi":"10.1080/00016489.2024.2400299","DOIUrl":"10.1080/00016489.2024.2400299","url":null,"abstract":"<p><strong>Background: </strong>Studies have shown that carotid artery reconstruction results in the best overall survival (OS) in Advanced Head and Neck Squamous Cell Carcinoma involving the Carotid Artery (AHNSCC-CA).</p><p><strong>Aims: </strong>The purpose of this study was to evaluate the efficacy of covered stent implantation combined with radical tumor resection and to compare and analyze the historical literature on conventional carotid artery resection and reconstruction.</p><p><strong>Materials and methods: </strong>A total of 68 patients with AHNSCC-CA were included in this study. This study compared the survival, local recurrence, surgical complications, and neurologic complications between the two groups.</p><p><strong>Results: </strong>The OS rate at 12 months in the experimental group was 58.5% (median survival time: 15 months, 95% CI: 7.61-22.40). The OS rate at 12 months in the control group was 34.3% (median survival time: 8 months, 95% CI: 3.94-12.06, <i>p</i> = .371). In addition, the differences in the rates of local recurrence, surgical complications and neurological complications between the two groups were statistically insignificant (<i>p</i> = .677, <i>p</i> = .197 and <i>p</i> = .617).</p><p><strong>Conclusions and significance: </strong>Compared with conventional carotid artery resection and reconstruction, covered stent implantation combined with radical tumor resection yields similar survival outcomes, but with significantly lower surgical risk and difficulty, and faster postoperative recovery.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"524-530"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Baseline eosinophil proportion is a useful predictor of immune-related adverse events following immune checkpoint inhibitor treatment for recurrent metastatic head and neck cancer.","authors":"Takayoshi Hattori, Tsutomu Ueda, Yuki Sato, Nobuyuki Chikuie, Takayuki Taruya, Takao Hamamoto, Minoru Hattori, Takashi Ishino, Sachio Takeno","doi":"10.1080/00016489.2024.2390084","DOIUrl":"10.1080/00016489.2024.2390084","url":null,"abstract":"<p><strong>Background: </strong>Immune checkpoint inhibitors (ICIs) occasionally cause immune-related adverse events (irAEs) in various organs. However, predictors of irAEs remain unidentified.</p><p><strong>Objectives: </strong>We evaluated the predictors of irAEs and compared the outcomes of ICIs with and without irAEs in patients with recurrent/metastatic head and neck cancers (R/M HNCs).</p><p><strong>Materials and methods: </strong>We retrospectively analyzed 157 patients with R/M HNCs who were administered an anti-PD-1 antibody between September 2014 and December 2022. We examined whether various pretreatment factors were associated with irAEs. The overall survival (OS) and progression-free survival (PFS) in patients with and without irAEs were analyzed.</p><p><strong>Results: </strong>Overall, 44 patients (28.0%) developed irAEs. The survival curve estimated for patients with and without irAEs showed a significant difference in PFS (<i>p</i> = 0.018), but not in OS (<i>p</i> = 0.208). Multivariate analysis revealed significant differences in relative eosinophil counts (<i>p</i> < 0.001), TP (<i>p</i> = 0.014), and NLR (<i>p</i> = 0.002), which may be independent predictors of irAEs.</p><p><strong>Conclusion: </strong>IrAEs may be associated with higher efficacy of ICIs and longer PFS. The relative eosinophil count may be predictors of irAEs and useful in routine medical practice. Using these biomarkers to predict irAEs will help predict ICI effects and manage irAEs.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"515-523"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta Oto-LaryngologicaPub Date : 2024-09-01Epub Date: 2024-09-20DOI: 10.1080/00016489.2024.2402542
Xu Liu, Linying Guo, Suming Shi, Wuqing Wang
{"title":"The characteristics of three-dimensional real inversion recovery MRI sequence in delayed Meniere's disease.","authors":"Xu Liu, Linying Guo, Suming Shi, Wuqing Wang","doi":"10.1080/00016489.2024.2402542","DOIUrl":"10.1080/00016489.2024.2402542","url":null,"abstract":"<p><strong>Background: </strong>Delayed Meniere's disease (DMD) is characterized by episodic vertigo occurring after a significant delay following longstanding sensorineural hearing loss. However, its pathogenesis and characteristics remain unclear.</p><p><strong>Objectives: </strong>To explore the characteristics of endolymphatic hydrops (EH) in DMD and investigate its pathology using MRI.</p><p><strong>Materials and methods: </strong>17 patients diagnosed with DMD were included in this study. A 3D-real-IR MRI sequence was utilized to visualize and grade EH. The signal intensity of the basal cochlear turn was compared to that of the cerebellar white matter to calculate the CC ratio. A paired <i>t</i>-test was employed to assess the differences in the CC ratio between the affected and unaffected sides in patients with unilateral DMD.</p><p><strong>Results: </strong>EH was present in 100% of cases on the affected side. Unilateral EH was seen in 82.4%, and bilateral EH in 23.5%. Vestibular EH without cochlear involvement occurred in 29.4%, and cochlear EH without vestibular involvement in 5.9%. The CC ratio was significantly higher on the affected side (<i>p</i> < 0.01).</p><p><strong>Conclusions and significance: </strong>A significant grade of vestibular EH was observed in DMD, with bilateral EH being relatively common. The increased contrast on the affected side may reflect the underlying pathology in DMD patients.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"491-494"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acta Oto-LaryngologicaPub Date : 2024-09-01Epub Date: 2024-09-21DOI: 10.1080/00016489.2024.2396487
Ruru Tian, Jianhua Jiang, Xiangyan Wu, Jie Ling Zhao, Xin Ru Zhou, Jinv Ding
{"title":"Based on the clinical features of cytologically intrinsic chronic rhinosinusitis with nasal polyps.","authors":"Ruru Tian, Jianhua Jiang, Xiangyan Wu, Jie Ling Zhao, Xin Ru Zhou, Jinv Ding","doi":"10.1080/00016489.2024.2396487","DOIUrl":"10.1080/00016489.2024.2396487","url":null,"abstract":"<p><strong>Background: </strong>The clinical phenotypes of CRS, such as the presence or absence of polyps, cannot well reflect the pathophysiological mechanisms and characteristics of patients. Only by distinguishing the different internal types of CRS can we individualize patients more accurately.</p><p><strong>Objective: </strong>To investigate the clinical characteristics of chronic rhinosinusitis with different cell types (CRSwNP), and to provide a reference for the diagnosis and treatment of CRSwNP.</p><p><strong>Materials and methods: </strong>The cytological endotypes of CRSwNP were divided into five groups by cluster analysis.</p><p><strong>Results: </strong>There was a significant difference in the proportion of CRSwNP with different endotypes. There were significant differences in peripheral blood eosinophils, cerebrovascular disease, and unilateral and bilateral nasal polyps among CRSWNP patients with different cytological types.</p><p><strong>Conclusions: </strong>Mixed CRSwNP and eosinophilic CRSwNP are the most common, while neutrophilic CRSWNP is the least common. Eosinophilic CRSwNP is more common in bilateral nasal polyps, with a high recurrence rate and a high probability of olfactory dysfunction. Neutrophilic CRSwNP is more common in elderly patients with cardiovascular and cerebrovascular diseases. Compared with total serum IgE, the percentage of eosinophils in peripheral blood is more helpful for the diagnosis of eosinophilic CRSwNP.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"509-514"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Shifting paradigms in endoscopic sinus surgery: a comprehensive analysis from Japan's national database.","authors":"Seiichiro Makihara, Kensuke Uraguchi, Shohei Fujimoto, Aiko Shimizu, Shin Kariya, Mitsuhiro Okano, Takashi Yorifuji, Mizuo Ando","doi":"10.1080/00016489.2024.2389179","DOIUrl":"10.1080/00016489.2024.2389179","url":null,"abstract":"<p><strong>Background: </strong>In 2013, Japan established a standardized classification system for categorizing endoscopic sinus surgery (ESS) into types I-V, yet no evaluation has been conducted thereof.</p><p><strong>Objective: </strong>We assessed the ESS trends and status in Japan, focusing on outpatient and inpatient surgeries.</p><p><strong>Material and methods: </strong>This descriptive retrospective cohort study used Japan's National Database of Health Insurance Claims and Specific Health Checkups between 2014 and 2021. The distribution of ESS types I-V and outpatient and inpatient surgeries was analysed, along with age groups and regional differences, focusing on ESS type III.</p><p><strong>Results: </strong>Overall, 427,813 ESS procedures were performed, with types III and IV being most common. Outpatient ESS type III increased substantially compared to inpatient surgeries. Younger individuals favoured outpatient ESS type III over inpatient surgeries, with substantial regional variations across prefectures.</p><p><strong>Conclusions and significance: </strong>The adoption of a standardized ESS classification in Japan has facilitated a detailed understanding of surgical trends. The shift toward outpatient surgeries, especially for type III ESS, aligns with global trends toward minimally invasive procedures and reflects changing patient preferences and healthcare delivery practices. Consequently, continuous monitoring and research are crucial for adapting surgical practices to the evolving healthcare needs and patient expectations.</p>","PeriodicalId":6880,"journal":{"name":"Acta Oto-Laryngologica","volume":" ","pages":"503-508"},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141915833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}